The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging
2017/01/17 by Mahul B. Amin, Frederick L. Greene, Stephen B. Edge +7 · 57 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer Genomics and Diagnostics #Breast Cancer Treatment Studies #Lung Cancer Treatments and Mutations
paper · pdf · doi:10.3322/caac.21388
Abstract
The American Joint Committee on Cancer (AJCC) staging manual has become the benchmark for classifying patients with cancer, defining prognosis, and determining the best treatment approaches. Many view the primary role of the tumor, lymph node, metastasis (TNM) system as that of a standardized classification system for evaluating cancer at a population level in terms of the extent of disease, both at initial presentation and after surgical treatment, and the overall impact of improvements in cancer treatment. The rapid evolution of knowledge in cancer biology and the discovery and validation of biologic factors that predict cancer outcome and response to treatment with better accuracy have led some cancer experts to question the utility of a TNM-based approach in clinical care at an individualized patient level. In the Eighth Edition of the AJCC Cancer Staging Manual, the goal of including relevant, nonanatomic (including molecular) factors has been foremost, although changes are made only when there is strong evidence for inclusion. The editorial board viewed this iteration as a proactive effort to continue to build the important bridge from a "population-based" to a more "personalized" approach to patient classification, one that forms the conceptual framework and foundation of cancer staging in the era of precision molecular oncology. The AJCC promulgates best staging practices through each new edition in an effort to provide cancer care providers with a powerful, knowledge-based resource for the battle against cancer. In this commentary, the authors highlight the overall organizational and structural changes as well as "what's new" in the Eighth Edition. It is hoped that this information will provide the reader with a better understanding of the rationale behind the aggregate proposed changes and the exciting developments in the upcoming edition. CA Cancer J Clin 2017;67:93-99. © 2017 American Cancer Society.
Cited by
- Breast cancer statistics 2024
- Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions
- Breast Cancer Statistics, 2022
- Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians
- Obstruction predicts worse long-term outcomes in stage III colon cancer: A secondary analysis of the N0147 trial
- Optimal policy tree to assist in adjuvant therapy decision-making after resection of colorectal liver metastases
- 2023 FIGO staging system for endometrial cancer: The evolution of the revolution
- Decoupling risk and masking in mammographic density under irregular follow up using a latent Markov progression detection framework
- The prognostic potential of CDX2 in colorectal cancer: Harmonizing biology and clinical practice
- État des lieux des pratiques de prise en charge des cancers des voies biliaires en France : résultats de l'enquête nationale ACABi
- Navigating Gigapixel Pathology Images with Large Multimodal Models
- An Anatomy Aware Hybrid Deep Learning Framework for Lung Cancer Tumor Stage Classification
- Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
- Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
- Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set
- Tumour burden predicts outcomes after curative resection of multifocal intrahepatic cholangiocarcinoma
- SUNSPOT CYCLE AND IONOSPHERIC STORMS. Environmental Research Papers
- Autofocusing technologies for whole slide imaging and automated microscopy
- Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data
- DCMIL: A Progressive Representation Learning of Whole Slide Images for Cancer Prognosis Analysis
- Surgical planning of small intestine neuroendocrine tumors: the concept of mesenteric tumor deposits
- Ki-67 Change in Anthracyline-containing Neoadjuvant Chemotherapy Response in Breast Cancer
- Clinical characteristics and prognosis of histological subtypes of papillary thyroid carcinoma in pediatric patients
- Clinical and prognostic significance of parathyroid hormone-related protein in breast cancer: a systematic review and meta-analyses of observational studies in women
- Soft tissue tumor imaging in adults: European Society of Musculoskeletal Radiology–Guidelines 2024: imaging immediately after neoadjuvant therapy in soft tissue sarcoma, soft tissue tumor surveillance, and the role of interventional radiology
- Real-world efficacy of lenvatinib/pembrolizumab combination in anaplastic thyroid carcinoma: case series from two Italian referral centers
- Insights into the Clinical Prognosis of High-grade Appendiceal Mucinous Neoplasms
- Impact of malnutrition diagnosed using Global Leadership Initiative on Malnutrition criteria on clinical outcomes of patients with gastric cancer
- Representación y análisis formal: lecciones de análisis de formas
- Benchmarking GPT-5 in Radiation Oncology: Measurable Gains, but Persistent Need for Expert Oversight
- Clinical presentation and outcomes of medullary thyroid cancer in two European countries: impact of diagnostic strategies
- 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer
- Exosomal Long Interspersed Nuclear Element‐1 Analytes Discriminate Histologic Subtypes, Sex, and Clinicopathological Characteristics of Patients with Non‐Small Cell Lung Cancer
- Breaking down tumor thrombus: Current strategies for medical management
- Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. [europepmc]
- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. [europepmc]
- Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study. [europepmc]
- Artificial intelligence in cancer imaging: Clinical challenges and applications. [europepmc]
- The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer. [europepmc]
- Pathways of Colorectal Carcinogenesis. [europepmc]
- Human papillomavirus as a driver of head and neck cancers. [europepmc]
- Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention. [europepmc]
- Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies. [europepmc]
- Gastric cancer: a comprehensive review of current and future treatment strategies. [europepmc]
- Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group. [europepmc]
- Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma. [europepmc]
- Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. [europepmc]
- Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia. [europepmc]
- Artificial intelligence for clinical oncology. [europepmc]
- Breast Cancer Treatments: Updates and New Challenges. [europepmc]
- Cancer of the ovary, fallopian tube, and peritoneum: 2021 update. [europepmc]
- Improved prediction of immune checkpoint blockade efficacy across multiple cancer types. [europepmc]
- Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature). [europepmc]
- Pan-cancer integrative histology-genomic analysis via multimodal deep learning. [europepmc]
- Signaling pathways and therapeutic interventions in gastric cancer. [europepmc]
- Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer. [europepmc]
- Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach. [europepmc]
- Metastasis. [europepmc]
- A pathology foundation model for cancer diagnosis and prognosis prediction. [europepmc]
Related